Rein Therapeutics Ownership | Who Owns Rein Therapeutics?


OverviewFinancialsChart

Rein Therapeutics Ownership Summary


Rein Therapeutics is owned by 10.34% institutional investors, 0.08% insiders, and 89.58% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 6.99% of RNTX shares.

RNTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRein Therapeutics10.34%0.08%89.58%
SectorHealthcare Stocks 232.20%10.74%-142.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp1.69M6.99%$1.94M
Voss capital1.43M5.93%$2.01M
Vanguard group1.17M4.42%$1.35M
University of texas/texas am investment managment511.61K2.12%$585.79K
Cable car capital420.00K1.74%$480.90K
Prosight management, lp442.60K1.68%$513.42K
Geode capital management284.56K1.08%$330.16K
Texas capital bank wealth management services262.13K0.99%$304.06K
Gagnon securities228.69K0.95%$261.85K
Sigma planning247.28K0.94%$298.62K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp1.69M2.19%$1.94M
Kck22.34K0.34%$52.05K
Cable car capital420.00K0.21%$480.90K
Abs direct equity fund125.00K0.17%$145.00K
Voss capital1.43M0.14%$2.01M
Prosight management, lp442.60K0.11%$513.42K
University of texas/texas am investment managment511.61K0.08%$585.79K
Gagnon securities228.69K0.05%$261.85K
Texas capital bank wealth management services262.13K0.02%$304.06K
Rock creek group, lp100.00K0.01%$116.00K

Top Buyers

HolderShares% AssetsChange
Texas capital bank wealth management services262.13K0.02%235.95K
Gagnon securities228.69K0.05%156.95K
Abs direct equity fund125.00K0.17%125.00K
Rock creek group, lp100.00K0.01%100.00K
Jane street group61.96K-61.96K

Top Sellers

HolderShares% AssetsChange
Prosight management, lp442.60K0.11%-125.30K
Exencial wealth advisors---30.53K
Two sigma securities---16.27K
Warberg asset management---11.00K
Sigma planning247.28K0.01%-6.55K

New Positions

HolderShares% AssetsChangeValue
Abs direct equity fund125.00K0.17%125.00K$145.00K
Rock creek group, lp100.00K0.01%100.00K$116.00K
Jane street group61.96K-61.96K$71.87K
Hrt financial lp33.24K0.00%33.24K$38.00K
Annandale capital15.03K0.00%15.03K$17.00K

Sold Out

HolderChange
Citigroup-1.00
Game plan financial advisors-25.00
Jpmorgan chase-32.00
Hexagon capital partners-213.00
Wells fargo & company/mn-1.69K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202522-43.59%2,725,534-67.89%100.84%11-15.38%2-75.00%
Sep 30, 202519-45.71%3,856,409-42.07%152.10%5-64.29%3-40.00%
Jun 30, 202535-5.41%6,657,20910.63%303,7610.04%14-62.16%5-
Mar 31, 202536-5,995,080-27,636-36---

Recent Insider Transactions


DateNameRoleActivityValue
Nov 14, 2025Voss Capital, LP-Buy$127.59K
Oct 27, 2025Voss Capital, LP-Buy$126.92K
Oct 24, 2025Voss Capital, LP-Buy$41.96K
Oct 28, 2025Voss Capital, LP-Buy$247.96K
Oct 27, 2025Voss Capital, LP-Buy$6.62K

Insider Transactions Trends


DateBuySell
2025 Q44-
2025 Q3--

RNTX Ownership FAQ


Who owns the most shares of Rein Therapeutics?

Rein Therapeutics’s largest shareholders are Bios capital management, lp (1.69M shares, 6.99%), Voss capital (1.43M shares, 5.93%), and Vanguard group (1.17M shares, 4.42%). Together, they hold 17.34% of Rein Therapeutics’s total shares outstanding.

Does Blackrock own Rein Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rein Therapeutics.

Who is Rein Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Rein Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.19% of its assets in 1.69M Rein Therapeutics shares, valued at 1.94M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools